Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SRZN stock hub

Surrozen, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SRZNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

332.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SRZN

In the news

Latest news · SRZN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SRZN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

USD

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001824893
Company name	Surrozen, Inc.
Country	United States
Country code	US
Cusip	86889P109
Employees	44
Employees Change	3%
Employees Change Percent	7.32
Enterprise value	$232.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US86889P2083
Last refreshed	2026-05-10
Market cap	$332.7M
Market cap category	Small-Cap
Price	$28.96
Price currency	USD
Rev Per Employee	170,318.18x
Sector	Healthcare
Sic	2836
Symbol	SRZN
Website	https://www.surrozen.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-102.98%
EV Sales Forward	82.22x
EV/Sales	31.03x
FCF yield	-10.12%
P/S ratio	44.39x
PS Forward	117.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-291.85%
Gross Profit	$-21.9M
Net Income	$-342.6M
Net Income Growth Years	0%
Pretax Margin	-4,571.14%
Profit Per Employee	$-7.8M
ROA	-22.82
Roa5y	-33.56
ROCE	-38.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	213.33%
Cagr3y	46.83%
Cagr5y	-27.82%
EPS Growth Years	0
Revenue Growth	-35.61x
Revenue Growth Q	408.65x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-15.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.06
Assets	$120.7M
Cash	$106.9M
Current Assets	$113.9M
Current Liabilities	$9.6M
Debt	$6.8M
Equity	$-278.1M
Liabilities	$398.9M
Long Term Assets	$6.8M
Long Term Liabilities	$389.3M
Net Cash	$100.1M
Net Cash By Market Cap	$30.1
Net Cash Growth	6.89%
Tangible Book Value	$-278.1M
Tangible Book Value Per Share	$-24.21
WACC	7.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.91
Net Working Capital	$-599,000
Quick ratio	11.7
Working Capital	$104.4M
Working Capital Turnover	$0.08

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-179.86%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	213.08%
200-day SMA	19.26
3Y total return	216.61%
50-day SMA	28.78
50-day SMA vs 200-day SMA	50over200
5Y total return	-80.4%
All Time High	210
All Time High Change	-86.21%
All Time High Date	2021-09-17
All Time Low	4.5
All Time Low Change	543.56%
All Time Low Date	2023-11-09
ATR	2.61
Beta	0.59
Beta1y	-0.75
Beta2y	-0.32
Ch YTD	28.14
High	30.95
High52	35
High52 Date	2026-05-07
High52ch	-17.26%
Low	28.55
Low52	5.9
Low52 Date	2025-05-16
Low52ch	390.85%
Ma50ch	0.63%
Premarket Change Percent	0.49
Premarket Price	$30.9
Premarket Volume	18,232
Price vs 200-day SMA	50.36%
RSI	45.92
RSI Monthly	60.61
RSI Weekly	59.27
Sharpe ratio	1.81x
Sortino ratio	2.98
Total Return	-179.86%
Tr YTD	28.14
Tr1m	12.38%
Tr1w	-13.81%
Tr3m	27.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$42
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.85
Earnings Revenue Estimate	4,200,000x
Operating Income	$-43M
Operating margin	-573.8
Price target	$42
Price Target Change	$45.03
Price Target Change Top	$45.03

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,790,821%
Float Percent	41.71%
Shares Insiders	0.57%
Shares Institutions	44.12%
Shares Out	11,486,707
Shares Qo Q	20.07%
Shares Yo Y	179.86%
Short Float	9.07%
Short Ratio	4.03
Short Shares	3.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-38.8M
Average Volume	139,848.05x
Bv Per Share	-24.21
CAPEX	$-221,000
Ch1m	12.38
Ch1w	-13.81
Ch1y	213.1
Ch3m	27.02
Ch3y	216.6
Ch5y	-80.4
Ch6m	137.4
Change	-5.82%
Change From Open	-6.43
Close	30.75
Days Gap	0.65
Depreciation Amortization	308,000
Dollar Volume	2,003,800.3
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-43M
EBITDA	$-42.7M
EPS	$-36.81
F Score	2
FCF	$-33.7M
FCF EV Yield	-14.49x
FCF Per Share	$-2.93
Financing CF	38,946,000
Fiscal Year End	December
Founded	2,015
Investing CF	-221,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Date	2023-12-14
Last Split Type	Reverse
Last10k Filing Date	2026-03-23
Ma150	21.93
Ma150ch	32.03%
Ma20	31.44
Ma20ch	-7.89%
Net CF	5,265,000
Next Earnings Date	2026-08-07
Open	30.95
Optionable	No
Position In Range	17.08
Post Close	28.96
Postmarket Change Percent	-0.21
Postmarket Price	$28.9
Ppne	6,038,000
Pre Close	30.75
Price Date	2026-05-08
Relative Volume	0.49x
Revenue	7,494,000x
SBC By Revenue	68.13x
Share Based Comp	5,106,000
Tr6m	137.38%
Us State	California
Volume	69,192

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SRZN pay a dividend?

Capital-return profile for this ticker.

Performance

SRZN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SRZN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.1%

Float: +41.7% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SRZN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.9

Neutral momentum band

Price vs 200-day MA

+50.4%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

1.81

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SRZN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SRZN stock rating?

Surrozen, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SRZN analysis?

The full report lives at /stocks/SRZN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SRZN?

The latest report frames SRZN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SRZN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.